RESEARCH-USE BIOSIMILAR ANTIBODY
Livmoniplimab
Monoclonal antibody · IgG4
Livmoniplimab (ABBV-151) is a monoclonal antibody against GARP/TGF-β1 that can inhibit the release of active TGF-β1. Livmoniplimab has anti-tumor activity in colon cancer mice. Livmoniplimab can be used for the study of locally advanced or metastatic solid tumors.
TARGETTGFB1
YMonoclonal antibody
TARGETLRRC32
CATALOG NUMBERSC-BS-411
MOLECULAR WEIGHTApprox. 146.22 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Livmoniplimab (ABBV-151) is a monoclonal antibody against GARP/TGF-β1 that can inhibit the release of active TGF-β1. Livmoniplimab has anti-tumor activity in colon cancer mice. Livmoniplimab can be used for the study of locally advanced or metastatic solid tumors.
Livmoniplimab is a recombinant research-use antibody directed against TGFB1 / LRRC32.